A Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease (SPIRR-CAD): Results of an

Christoph Herrmann-Lingen1, Manfred E Beutel, Alexandra Bosbach

  • 1From the Department of Psychosomatic Medicine and Psychotherapy (Herrmann-Lingen, Bosbach), University of Göttingen Medical Center and German Center for Cardiovascular Research, Partner Site Göttingen, Göttingen, Germany; Department of Psychosomatic Medicine and Psychotherapy (Beutel, Michal), University Medical Center Mainz, Mainz, Germany; Department of Psychosomatics and Psychotherapy (Deter, Weber), Charité Universitaetsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany; Department of Psychosomatic Medicine and Psychotherapy (Fritzsche), University Medical Center Freiburg, Freiburg, Germany; Institute of Medical Statistics (Hellmich), Informatics and Epidemiology, University of Cologne, Köln, Germany; Clinic of Psychocardiology (Jordan), Kerckhoff Rehabilitation Center, Bad Nauheim, Germany; Department of General Internal and Psychosomatic Medicine (Jünger), University of Heidelberg, Heidelberg, Germany; Institute of Epidemiology (Ladwig), Helmholtz Zentrum München, German Research Center for Environmental Health, Oberschleißheim, Germany; Department of Psychotherapy and Psychosomatics (Petrowski), Technical University of Dresden, Dresden, Germany; Department of Internal Medicine and Cardiology, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, Department of Internal Medicine and Cardiology, German Heart Cente, and German Center for Cardiovascular Research, Partner Site Berlin, Berlin, Germany (Pieske); Department of Psychosomatic Medicine and Psychotherapy (Ronel), University Hospital Rechts der Isar, Technische Universitaet Muenchen, Munich, Germany; Department of Psychosomatic Medicine and Psychotherapy (Söllner), Paracelsus Medical University, Nuremberg General Hospital, Nuremberg, Germany; Clinical Trials Center (Stöhr), University of Cologne, Köln, Germany; Department of Psychosomatic Medicine and Psychotherapy (de Zwaan), Hannover Medical School, Hannover, Germany; and Department of Psychosomatics and Psychotherapy (Albus),

Insights

Stepwise psychotherapy did not significantly improve depression in coronary artery disease (CAD) patients compared to information sessions. However, Type D personality may predict a better response to psychotherapy in these patients.

Area of Science:

  • Cardiology
  • Psychiatry
  • Clinical Psychology

Background:

  • Depression is linked to worse outcomes in coronary artery disease (CAD) patients.
  • Previous studies on treating depression in CAD have shown inconsistent results.

Purpose of the Study:

  • To test if stepwise psychotherapy is more effective than simple information for improving depressive symptoms in CAD patients.
  • To investigate if patient sex or Type D personality influences treatment response.

Main Methods:

  • A multicenter trial randomized 570 CAD patients with elevated depressive symptoms.
  • Patients received usual care plus either one information session (UC-IS) or stepwise psychotherapy (UC-PT).
  • The primary outcome was the change in depressive symptoms over 18 months, with subgroup analyses for sex and Type D personality.

Main Results:

  • Both UC-PT and UC-IS groups showed significant reductions in depressive symptoms (p < .001).
  • There was no significant overall difference in symptom improvement between the two groups (p = .90).
  • A significant interaction was found for Type D personality (p = .026), with a trend towards greater improvement with UC-PT in Type D patients (p = .057).

Conclusions:

  • Stepwise psychotherapy did not outperform simple information sessions in reducing depressive symptoms in CAD patients.
  • Type D personality may identify CAD patients who could benefit more from stepwise psychotherapy.
  • Further research is needed to confirm the efficacy of psychotherapy for Type D CAD patients.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
391
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
569
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
835
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
429
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
539